Another promising application is the development of a cell cycle inhibitor, which blocks cell growth. Cramer says this prodnct may be able to help prevent cancer. Tlhird, Cramer and colleagues are investigating a potential clot buster, or serum protein with anticoagulant properties, that she says tobacco produces in a fully active form. Genetically, engineering tobacco anid other plants to gener-ate pi-oteiin-based polymers, however, is nIoiC en vionmentally friendlyt because the productionI process does nlot require hazardous chemicals. Furthermore, scientists canl design the polymers to be biodegradable bs "installing" chemical clocks to determline the polymers' half-lives. Daniell's group has expressed polymers derived fronm human elastini genes into tobacco plants. Scientists at Bioelastics have found that these comnpounds canl be absorbed by the skin and are biocomiipatible, which demonstrates their potential for use in medical applicationis such as the prevention of postsurgical adhesions (fibrous tissue formed in response to surgical manipulation of internal organs), as well as in tissue reconstruction anid programmed drug delivery. Bioelastics hopes to soon begin conducting clinical trials on the use of a polymer produced in z'scherichia coli and tobacco for the preventioni of postsurgical adhesions.
Daniell believes the Imlost fihnanciallIN Innovations * Turning over a New Leaf and then must be purified, a process that is lengthy and that recovers small amounts, making the end product very expensive, Daniell says. Daniell and colleagues are developing a one-step process in which insulin is purified in tobacco. He says the potential exists for tobacco to produce large amounts of insulin. The researchers are currently in the process of expressing insulin in tobacco plant genes, and Daniell says the insulin could be ready for clinical trials next year. Daniell's lab is also using tobacco to develop vaccines, induding one for cholera, a disease that can cause diarrhea, dehydration, and death.
Implementation
There is concern about the introduction of genetically manipulated plants into nature because of the potential for foreign genes to escape through pollen dispersal, but Daniell says that tobacco is safe. Tobacco plants mainly self-pollinate and there is no evidence of any hybrids in nature. Therefore, he says, there is little risk of transfer ofgenetic material to other plants. While tobacco does have advantages over other crops in the manufacture of genetically engineered products, some adjustments need to be made in order for the plant to be competitive with other crops. "We're trying to work out the kinks of tobacco production in order for it to be the plant of choice," says Davies. "Certainly the potential is there.'
One issue is that the production costs of tobacco are much higher than the production costs of other crops such as corn and soybeans. The high costs are due to tobacco's unusual production style, which involves manual harvesting. The high price that tobacco currently commands allows farmers to support this high-cost production style.
Davies says that to achieve lower production costs, the development of new varieties of tobacco will be pursued. "The tobacco of the future will probably be quite a different-looking crop than [that of] today," he says. For example, THRI researchers are working to extend the life of tobacco leaves, thereby increasing the production amount of genetically engineered compounds.
Most important, however, Long says more money is needed for further research. "The failing is less in the science and technology, and more in funding," agrees Lou Tornatzky, a senior fellow with the Southern Technology Council, an organization based in Research Triangle Park, North Carolina, that works to strengthen the regional economy through the more effective development, commercialization, and deployment of technology. In March 1996, the group published a market analy- 
